Viscofan Balance Sheet Health
Financial Health criteria checks 5/6
Viscofan has a total shareholder equity of €956.2M and total debt of €265.6M, which brings its debt-to-equity ratio to 27.8%. Its total assets and total liabilities are €1.4B and €477.9M respectively. Viscofan's EBIT is €183.8M making its interest coverage ratio 29.5. It has cash and short-term investments of €58.3M.
Key information
27.8%
Debt to equity ratio
€265.57m
Debt
Interest coverage ratio | 29.5x |
Cash | €58.26m |
Equity | €956.17m |
Total liabilities | €477.88m |
Total assets | €1.43b |
Recent financial health updates
Is Viscofan (BME:VIS) Using Too Much Debt?
Dec 21Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 20Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly
May 25Is Viscofan (BME:VIS) Using Too Much Debt?
Jan 07Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 01Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?
Mar 25Recent updates
Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Apr 20Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All
Apr 11Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?
Apr 04Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio
Mar 18Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement
Jan 17Is Viscofan (BME:VIS) Using Too Much Debt?
Dec 21Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?
Nov 15Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 20Returns On Capital At Viscofan (BME:VIS) Have Stalled
Aug 29Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?
Aug 11Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly
May 25Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374
May 04Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching
Apr 24The Returns At Viscofan (BME:VIS) Aren't Growing
Mar 02Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)
Feb 16Is Viscofan (BME:VIS) Using Too Much Debt?
Jan 07Returns On Capital At Viscofan (BME:VIS) Have Stalled
Nov 29Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price
Nov 11Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet
Sep 01Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger
Aug 03Viscofan's (BME:VIS) Returns Have Hit A Wall
May 03Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?
Mar 25Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?
Mar 06Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching
Jan 15Returns At Viscofan (BME:VIS) Appear To Be Weighed Down
Dec 29Viscofan (BME:VIS) Has A Rock Solid Balance Sheet
Nov 24Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?
Oct 10With EPS Growth And More, Viscofan (BME:VIS) Is Interesting
Sep 23Returns On Capital At Viscofan (BME:VIS) Have Stalled
Aug 19Viscofan (BME:VIS) Has A Rock Solid Balance Sheet
Aug 03A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)
May 17Viscofan (BME:VIS) Could Easily Take On More Debt
Apr 07Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?
Mar 04Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like
Feb 17Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 02A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)
Jan 18Why Viscofan's (BME:VIS) CEO Pay Matters
Dec 26Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon
Dec 13Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?
Dec 04The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come
Nov 19Financial Position Analysis
Short Term Liabilities: VIS's short term assets (€800.7M) exceed its short term liabilities (€359.0M).
Long Term Liabilities: VIS's short term assets (€800.7M) exceed its long term liabilities (€118.9M).
Debt to Equity History and Analysis
Debt Level: VIS's net debt to equity ratio (21.7%) is considered satisfactory.
Reducing Debt: VIS's debt to equity ratio has increased from 18.7% to 27.8% over the past 5 years.
Debt Coverage: VIS's debt is well covered by operating cash flow (54.9%).
Interest Coverage: VIS's interest payments on its debt are well covered by EBIT (29.5x coverage).